SANOFI Stock Swiss Exchange
Stocks
SASY
FR0000120578
Pharmaceuticals
OTC Markets Traded| Market Cap | 92.83B 106B 85.68B 78.92B 149B 10,225B 152B 1,024B 402B 5,006B 399B 390B 17,243B | P/E 2026 * |
11.7x | P/E 2027 * | 10.7x |
|---|---|---|---|---|---|
| Enterprise Value | 102B 117B 94.57B 87.11B 164B 11,286B 168B 1,131B 444B 5,525B 440B 430B 19,033B | EV / Sales 2026 * |
2.18x | EV / Sales 2027 * | 1.97x |
| Free-Float |
89% | Yield 2026 * |
5.5% | Yield 2027 * | 5.83% |
Last Transcript: SANOFI
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 2026-04-30 | |
| Director of Finance/CFO | 64 | 2024-03-31 | |
Houman Ashrafian
CTO | Chief Tech/Sci/R&D Officer | 51 | 2023-09-10 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 60 | 2019-04-29 | |
Rachel Duan
BRD | Director/Board Member | 57 | 2020-04-27 |
Lise Kingo
BRD | Director/Board Member | 64 | 2020-04-27 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 106B | |
| +0.85% | -3.11% | +49.29% | +162.34% | 1,043B | |
| +1.23% | -2.34% | +53.56% | +58.28% | 602B | |
| +0.04% | +1.83% | +33.53% | +87.11% | 449B | |
| +0.78% | -0.39% | +30.44% | +23.23% | 327B | |
| +1.41% | +0.56% | +31.41% | +47.13% | 279B | |
| -0.27% | -5.69% | +20.68% | +21.99% | 264B | |
| -1.42% | +0.73% | +22.50% | +61.06% | 201B | |
| -1.48% | -0.42% | +22.24% | +73.96% | 169B | |
| -0.36% | +3.30% | +1.79% | -31.03% | 143B | |
| Average | -0.13% | -0.68% | +29.49% | +56.01% | 386.34B | |
| Weighted average by Cap. | -0.11% | -1.82% | +37.79% | +83.50% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 46.95B 53.7B 43.34B 39.92B 75.28B 5,172B 76.9B 518B 204B 2,532B 202B 197B 8,722B | 50.04B 57.23B 46.19B 42.54B 80.23B 5,512B 81.95B 552B 217B 2,698B 215B 210B 9,295B |
| Net income | 7.99B 9.14B 7.38B 6.79B 12.81B 880B 13.09B 88.17B 34.64B 431B 34.32B 33.56B 1,484B | 8.9B 10.18B 8.22B 7.57B 14.27B 981B 14.58B 98.24B 38.59B 480B 38.24B 37.4B 1,654B |
| Net Debt | 9.63B 11.02B 8.89B 8.19B 15.44B 1,061B 15.77B 106B 41.75B 519B 41.37B 40.46B 1,789B | 5.52B 6.31B 5.09B 4.69B 8.85B 608B 9.04B 60.9B 23.93B 298B 23.71B 23.18B 1,025B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Choose MarketScreener 
